Event-Driven Investment Opportunities, Special Situation Investments

Special Situation Investments

Event-Driven Investment Opportunities

Focus on event-driven trades and low risk arbitrage opportunities with short term catalysts

Event-Driven

<ul><li>Theratechnologies (THTX) received takeover offers from Future Pak, with a $3.51/share cash offer plus a CVR worth $0.99/share.</li><li>Naturgy Energy Group (NTGY:MC) plans to repurchase 9% of shares at €26.5/share, with priority for tenders below 375 shares.</li><li>Lensar (LNSR) is being acquired by Alcon for $14/share cash plus a CVR worth up to $2.75/share.</li></ul>

Theratechnologies (THTX) received takeover offers from Future Pak, with a $3.51/share cash offer plus a CVR worth $0.99/share.Naturgy Energy Group (NTGY:MC) plans to repurchase 9% of shares at €26.5/share, with priority for tenders below 375 shares.Lensar (LNSR) is being acquired by Alcon for $14/share cash plus a CVR worth up to $2.75/share.

Analyzing Active Quick Pitches: Takeovers, Tender Offers, Strategic Reviews and More

<ul><li>Theratechnologies (THTX) received a non-binding takeover offer from Future Pak, with a potential 62% upside including CVR.</li><li>Merck KGaA is nearing a $47/share acquisition of SpringWorks Therapeutics (SWTX), with no competing bidders reported.</li><li>Liquidia (LQDA) and UTHR are engaged in legal battles over patent infringement and Yutrepia’s approval, affecting market valuations.</li></ul>

Theratechnologies (THTX) received a non-binding takeover offer from Future Pak, with a potential 62% upside including CVR.Merck KGaA is nearing a $47/share acquisition of SpringWorks Therapeutics (SWTX), with no competing bidders reported.Liquidia (LQDA) and UTHR are engaged in legal battles over patent infringement and Yutrepia’s approval, affecting market valuations.

Potential Takeovers, Legal Battles, and Strategic Reviews: Key Updates on THTX, SWTX, LQDA and More

<ul><li>Naturgy Energy Group plans to repurchase 9% of shares at €26.5/share, with an odd-lot priority rule.</li><li>Assura is involved in a potential bidding war with two credible bidders, offering free optionality on further bids.</li><li>VH Global Energy Infrastructure announced a 3-year asset realization plan, trading at a 35% discount to NAV.</li></ul>

Naturgy Energy Group plans to repurchase 9% of shares at €26.5/share, with an odd-lot priority rule.Assura is involved in a potential bidding war with two credible bidders, offering free optionality on further bids.VH Global Energy Infrastructure announced a 3-year asset realization plan, trading at a 35% discount to NAV.

Current Active Quick Pitches: Mergers, Liquidations, Tender Offers, and More

United States

Theratechnologies Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH), and oncology. Theratechnologies serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00